Cargando…

Prospective evaluation of the diagnostic value of plasma apelin 12 levels for differentiating patients with moyamoya and intracranial atherosclerotic diseases

Patients with moyamoya disease (MMD) or intracranial atherosclerotic disease (ICAD) experience similar cerebral ischaemic events. However, MMD patients show greater angiogenesis and arteriogenesis, which play crucial roles in collateral circulation development to enhance clinical prognosis and outco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Wei, Jiang, Wan, Ye, Li, Tian, Yanghua, Shen, Bing, Wang, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511181/ https://www.ncbi.nlm.nih.gov/pubmed/28710384 http://dx.doi.org/10.1038/s41598-017-05664-8

Ejemplares similares

Intracranial Vasculopathy in a Patient with Systemic Sclerosis: Atherosclerotic or Moyamoya-Like Disease?
por: Choi, Han Na, et al.
Publicado: (2012)

Correlation Between Apelin and Collateral Circulation in Patients with Middle Cerebral Artery Occlusion and Moyamoya Disease
por: Wu, Hanlin, et al.
Publicado: (2022)

Intracranial Atherosclerotic Disease
por: Khan, Maria, et al.
Publicado: (2011)

Predictive value of apelin-12 in patients with ST-elevation myocardial infarction with different renal function: a prospective observational study
por: Yang, Lingchang, et al.
Publicado: (2017)

The Association of Plasma Apelin Levels with Plaque Vulnerability
por: Keskin, Kudret, et al.
Publicado: (2019)

(1)H-NMR-Based Metabolomic Analysis of Cerebrospinal Fluid From Adult Bilateral Moyamoya Disease: Comparison With Unilateral Moyamoya Disease and Atherosclerotic Stenosis
por: Jeon, Jin Pyeong, et al.
Publicado: (2015)

Moyamoya disease: Diagnostic imaging
por: Tarasów, Eugeniusz, et al.
Publicado: (2011)

Natural course and risk factors of moyamoya disease with unruptured intracranial aneurysm
por: Yang, Ri-Miao, et al.
Publicado: (2023)

Intracranial Hemodynamic Changes During Adult Moyamoya Disease Progression
por: Kwag, Hyun-Jeong, et al.
Publicado: (2008)

Moyamoya Disease in Pregnancy: Management after Intracranial Bypass Grafting
por: Gimovsky, A. C., et al.
Publicado: (2012)

Extracranial and Intracranial Vasculopathy With “Moyamoya Phenomenon” in Association With Alagille Syndrome
por: Delaney, Siobhan, et al.
Publicado: (2019)

Clinical Features and Outcomes of Intracranial Aneurysm Associated with Moyamoya Disease
por: Kim, Sunghan, et al.
Publicado: (2020)

Endovascular Treatment of Intracranial Atherosclerotic Stenosis: Current Debates and Future Prospects
por: Luo, Jichang, et al.
Publicado: (2018)

On Methods for the Measurement of the Apelin Receptor Ligand Apelin
por: Janssens, Peter, et al.
Publicado: (2022)

The Effects of Apelin and Elabela Ligands on Apelin Receptor Distinct Signaling Profiles
por: Jiang, Yunlu, et al.
Publicado: (2021)

Plasma apelin level in acute myocardial infarction and its relation with prognosis: A prospective study
por: Guzelburc, Ozge, et al.
Publicado: (2021)

Increased abundance of Ruminococcus gnavus in gut microbiota is associated with moyamoya disease and non-moyamoya intracranial large artery disease
por: Mineharu, Yohei, et al.
Publicado: (2022)

Apelin and apelin receptor expression in renal cell carcinoma
por: Tolkach, Yuri, et al.
Publicado: (2019)

Association of apelin and apelin receptor with the risk of coronary artery disease: a meta-analysis of observational studies
por: Chen, Tianbao, et al.
Publicado: (2017)

Adult Moyamoya Disease: A Burden of Intracranial Stenosis in East Asians?
por: Bang, Oh Young, et al.
Publicado: (2015)

Application of FLOW 800 in extracranial-to-intracranial bypass surgery for moyamoya disease
por: Yim, Benjamin, et al.
Publicado: (2022)

Natural History of Intracranial Atherosclerotic Disease
por: Pu, Yuehua, et al.
Publicado: (2014)

Update in the treatment of intracranial atherosclerotic disease
por: Barnard, Zachary R, et al.
Publicado: (2019)

Precision Medicine for Intracranial Atherosclerotic Disease
por: Liebeskind, David S.
Publicado: (2021)

Significance and Determinants of Plasma Apelin in Patients With Obstructive Hypertrophic Cardiomyopathy
por: Yang, Chengzhi, et al.
Publicado: (2022)

Association of peripheral neutrophil count with intracranial atherosclerotic stenosis
por: Zhang, Xing, et al.
Publicado: (2020)

Importance of lipid ratios for predicting intracranial atherosclerotic stenosis
por: Yang, Wen-Song, et al.
Publicado: (2020)

Microstructural damage pattern of vascular cognitive impairment: a comparison between moyamoya disease and cerebrovascular atherosclerotic disease
por: Su, Jia-Bin, et al.
Publicado: (2019)

Elevated homocysteine as an independent risk for intracranial atherosclerotic stenosis
por: Liu, Ying, et al.
Publicado: (2019)

Intracranial Spotty Calcium Predicts Recurrent Stroke in Patients with Symptomatic Intracranial Atherosclerotic Stenosis: A Prospective Cohort Study
por: Li, Rui, et al.
Publicado: (2023)

Plasma urea cycle metabolite levels and the risk of moyamoya disease
por: Yu, Xiaofan, et al.
Publicado: (2023)

Prognostic Value of Combining Apelin-12 and Estimated Glomerular Filtration Rate in Patients with ST-Segment Elevation Myocardial Infarction
por: Liu, Yue, et al.
Publicado: (2022)

Effects of structural analogues of apelin-12 in acute myocardial infarction in rats
por: Pisarenko, Oleg I., et al.
Publicado: (2013)

Influence of apelin-12 on troponin levels and the rate of MACE in STEMI patients
por: Krasniqi, Xhevdet, et al.
Publicado: (2017)

The Evolving Paradigm in the Management of Intracranial Atherosclerotic Disease
por: Ozturk, Ali K., et al.
Publicado: (2012)

New Standards for Intracranial Atherosclerotic Disease Treatment
por: Nguyen, Thanh N., et al.
Publicado: (2011)

Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Disease
por: Short, Jody L., et al.
Publicado: (2011)

High-Resolution MRI of Intracranial Atherosclerotic Disease
por: Ryu, Chang-Woo, et al.
Publicado: (2014)

Neovascularization in Human Intracranial Atherosclerotic In-Stent Restenosis
por: Feng, Yiding, et al.
Publicado: (2021)

Recurrent stroke risk in intracranial atherosclerotic disease
por: Ballout, Ahmad A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tfhpt88ingo6oqbf8l6q9cfkma